tetano
Editor, Senior Moderator
JAAD Int
. 2021 Dec 28.
doi: 10.1016/j.jdin.2021.12.009. Online ahead of print.
Recurrent erythema nodosum after second dose of the Pfizer-BioNTech BNT162b2 COVID-19 messenger RNA vaccine
Xiaotian Wu, Joel Lim Hua Liang, Joyce Lee Siong See, Martin Tw Chio
Abstract
Vaccine induced erythema nodosum (EN) is well recognized. In this letter, we report a case of a patient who developed recurrent EN following vaccination with the Pfizer-BioNTech BNT162b2 COVID-19 messenger RNA (mRNA) vaccine. Clinicians should be aware that COVID-19 mRNA vaccines can be a possible cause of EN.
Keywords: COVID-19; coronavirus; drug-induced; erythema nodosum; panniculitis; tozinameran; vaccine.
. 2021 Dec 28.
doi: 10.1016/j.jdin.2021.12.009. Online ahead of print.
Recurrent erythema nodosum after second dose of the Pfizer-BioNTech BNT162b2 COVID-19 messenger RNA vaccine
Xiaotian Wu, Joel Lim Hua Liang, Joyce Lee Siong See, Martin Tw Chio
- PMID: 34977819
- PMCID: PMC8712276
- DOI: 10.1016/j.jdin.2021.12.009
Abstract
Vaccine induced erythema nodosum (EN) is well recognized. In this letter, we report a case of a patient who developed recurrent EN following vaccination with the Pfizer-BioNTech BNT162b2 COVID-19 messenger RNA (mRNA) vaccine. Clinicians should be aware that COVID-19 mRNA vaccines can be a possible cause of EN.
Keywords: COVID-19; coronavirus; drug-induced; erythema nodosum; panniculitis; tozinameran; vaccine.